📄 Redirect examination of Dr. John Gerdes (morning) — Monday, August 7, 1995
Address:
C:\DEPT103\CRIMINAL\1995\AUG\7\REDIRECT-EXAMINATION-OF-DR-JOH.DOC
TRIAL
▲ Day 130 of 167

Redirect examination of Dr. John Gerdes (morning)

Witness: Dr. John Gerdes
Examiner: Barry Scheck
Called by: Defense • Date: Monday, August 7, 1995 • Utterances: 285
Barry Scheck conducted redirect examination of DNA expert Dr. John Gerdes, focusing on his core contamination theory: that cross-contamination at the LAPD evidence processing room on June 13-14, 1994 would replicate across all subsequent testing by any laboratory. Scheck walked Gerdes through the handling of Bundy blood drops 47-52 alongside Simpson's reference sample, then pivoted to a key anomaly — item 117 (rear gate) showed no bacterial degradation and contained 150 nanograms of DNA, five times more than any Bundy blood drop, despite allegedly being collected from an outdoor crime scene weeks later using the same methods.
1 (Brief pause.)
2 (The following proceedings were held in open court, in the presence of the jury:)
3 THE COURT:

All right. Thank you, ladies and gentlemen. Please be seated. Dr. Gerdes. The record should reflect all the jurors have rejoined us. Dr. John Gerdes is on the witness stand again undergoing redirect examination by Mr. Scheck.

4 MR. SCHECK:

Good afternoon (Sic), ladies and gentlemen of the jury.

THE JURY: Good afternoon.

REDIRECT EXAMINATION BY MR. SCHECK

5 MR. SCHECK:

Dr. Gerdes, Mr. Clarke asked you quite a few questions about retyping by other laboratories?

6 DR. GERDES:

Yes.

7 MR. SCHECK:

Now, in terms of an initial cross-contamination of samples at the LAPD, does it matter how many other laboratories typed the samples if they were cross-contaminated initially at LAPD?

8 DR. GERDES:

No. Once you've accidentally or some other way transferred that DNA from one sample to another, it doesn't matter how many gene systems, how many different labs, it is always going to transfer, it is always going to type as the DNA that was transferred.

KEY QUOTE
9 MR. SCHECK:

Now, Mr. Clarke showed you what has been marked 564-F which is a series of slides, if I could put this up on the elmo, please, with respect to typing performed at the LAPD laboratory with respect to three of the five Bundy blood drop samples. Will you put that up there, please. In terms of--

10 THE COURT:

It is getting washed out here.

11 MR. SCHECK:

Yeah.

12 THE COURT:

There we go.

13 MR. SCHECK:

Now, listed on this chart are only items 48, 50 and 52; is that correct?

14 DR. GERDES:

Correct.

15 MR. SCHECK:

In terms of what was handled by Collin Yamauchi between nine o'clock and 11:00 on the morning of June 14th, were samples 47, 48, 49, 50, 52 and the Rockingham glove all sampled at that time with Mr. Simpson's reference sample?

16 DR. GERDES:

That's correct.

17 MR. SCHECK:

All right. And where did that occur?

18 DR. GERDES:

That occurred in the evidence processing room.

19 MR. SCHECK:

All right. And in terms of the drying of samples, and packaging of samples, were items 47, 48, 49, 50 and 52, along with Rockingham items, including item no. 12, the drops taken from the foyer of Mr. Simpson's home, were they all taken out of plastic bags, wet swatches and put into test tubes by Mr. Fung and Miss Mazzola without changing gloves and without changing papers on June 13th as is indicated under the section "Drying" on 6/13?

20 MR. CLARKE:

Objection, misstates the evidence.

21 THE COURT:

Sustained.

22 MR. SCHECK:

Well, based on your review of the testimony did Miss Mazzola and Mr. Fung take out of plastic bags swatches that they described were wet, put them into test tubes for drying on the evening of June 13th which included 47, 48, 49, 50 and 52, and the different samples collected at Rockingham?

23 DR. GERDES:

They did.

24 MR. SCHECK:

All right. And that would comport with the section of the chart marked "Drying," correct?

25 DR. GERDES:

That's correct.

26 MR. SCHECK:

And on June 14th in the morning did Mr. Fung and Miss Mazzola scrape out of test tubes using a pipette without changing gloves and without changing paper, put into bindles the swatches that they had previously dried on June 13th?

27 DR. GERDES:

They did.

28 MR. SCHECK:

Now, is it--what is your opinion about the way that Mr. Fung and Miss Mazzola handled those samples on June 13th and on June 14th in terms of the danger of cross-contamination?

29 DR. GERDES:

I think there is significant risk of cross-contamination because they didn't change gloves because they create aerosols when they try and scrape these little swatches out of the tube, and because they handled the reference sample at the same time as all of these other evidence items and because certain items--

30 MR. CLARKE:

Excuse me. Sorry. Objection, misstates the testimony.

31 THE COURT:

Overruled.

32 DR. GERDES:

And because certain items--a number of items, in fact, were mixed between crime scenes in terms of being handled at the same time.

33 MR. SCHECK:

Incidentally, item no. 12, the drops from the floor in the foyer from Mr. Simpson's residence, was that among the last samples collected on June 13th?

34 MR. CLARKE:

Objection, no foundation.

35 THE COURT:

Sustained.

36 MR. SCHECK:

Do you know if those were among the last samples collected by Mr. Fung and Miss Mazzola on June 13th?

37 MR. CLARKE:

Same objection.

38 THE COURT:

Sustained. Sustained.

39 MR. SCHECK:

All right.

40 THE COURT:

Foundation, counsel.

41 MR. SCHECK:

Are you familiar with the testimony and the records concerning the collection of the items at Rockingham?

42 DR. GERDES:

Yes.

43 MR. SCHECK:

All right. Was item no. 12 one of the last items collected on June 13th?

44 DR. GERDES:

Yes.

45 MR. SCHECK:

And in terms of DNA concentration, was the concentration of item no. 12, in terms of human DNA, higher significantly than the Bundy blood drops?

46 DR. GERDES:

It was.

47 MR. SCHECK:

All right. And when that sample is handled in conjunction with the Bundy blood drops, in the fashion that you have just reviewed on June 13th and on June 14th, does that create a danger of cross-contamination with that sample?

48 DR. GERDES:

Yes, because you are handling a sample that has a large amount of DNA with samples that are degraded and small amounts of DNA.

49 MR. SCHECK:

And the samples that had degraded and small amounts of DNA were which sample?

50 DR. GERDES:

The Bundy blood drops.

51 MR. SCHECK:

Now, also--well, could you--could we circle on this--the evidence processing room on this flow chart as indicated 6/13 and 6/14. Could we draw a circle around that, Mr. Harris, and may I suggest pink. No, no, no, that is the evidence--

52 (Discussion held off the record between Defense counsel.)
53 MR. SCHECK:

No, no. All right. Thank you.

54 MR. SCHECK:

Dr. Gerdes, is it your testimony that it is in these procedures on June 13th and June 14th that unacceptable risks of cross-contamination occurred?

55 DR. GERDES:

Yes. The risk at the very first step that is circled.

56 MR. SCHECK:

And if those--cross-contamination to those samples, Bundy blood drops and the Rockingham glove, occurred at that time, would results be replicated by Cellmark, DOJ, your own laboratory, if you typed these kind of samples, Dr. Blake, Dr. Henry Lee or anyone else you found, assuming that they performed the tests correctly?

57 DR. GERDES:

They would.

58 MR. SCHECK:

Thank you. Can we print that out mark that as Defense next in order.

59 THE COURT:

1311.

60 (Deft's 1311 for id = photograph)
61 MR. SCHECK:

With the Court's permission could we turn the lights up and I will go over to a chart.

62 (Brief pause.)
63 THE COURT:

All right. This is 259, I believe the Bundy results board.

64 MR. SCHECK:

And your Honor, at the same time I would like to put up on the elmo what has previously been marked as Defendant's 1165. These are the charts of the amounts of nanograms of DNA.

65 (Brief pause.)
66 (Discussion held off the record between Defense counsel.)
67 MR. SCHECK:

Dr. Gerdes, starting with what is marked as 47--

68 DR. GERDES:

Yes.

69 MR. SCHECK:

--was that one of the Bundy blood drops that was handled by Dennis Fung and Andrea Mazzola on June 13th?

70 DR. GERDES:

Yes.

71 MR. SCHECK:

Was it one of the items that Mr. Yamauchi handled at the same period that he was handling Mr. Simpson's reference sample?

72 DR. GERDES:

Yes.

73 MR. CLARKE:

Objection, no foundation.

74 THE COURT:

Overruled.

75 MR. SCHECK:

This is when Mr. Yamauchi took out the stopper and the blood went through the chem wipe onto his glove?

76 DR. GERDES:

That's correct.

77 MR. SCHECK:

48 the same?

78 DR. GERDES:

Correct.

79 MR. SCHECK:

49 the same?

80 DR. GERDES:

Yes.

81 MR. SCHECK:

50 the same?

82 DR. GERDES:

Yes.

83 MR. SCHECK:

52 the same?

84 DR. GERDES:

Yes.

85 MR. SCHECK:

Now, 52, in terms of which of the Bundy blood drops swatches were opened up from the bindles, when Mr. Yamauchi began handling them on the morning of June 14th, which of the items did he handle first?

86 DR. GERDES:

No. 52.

87 MR. SCHECK:

Are you familiar with the estimate of the amount of human DNA in each of the Bundy blood drops, 47 through 52, as testified to by Gary Sims based on his calculation has from slot-blots, yield gels and the size of the swatches and their weight?

88 DR. GERDES:

Yes, I am.

89 MR. SCHECK:

All right. Do you regard those as accurate estimates as to the total number of nanograms of human DNA in those items?

90 DR. GERDES:

Yes, they are consistent with his notes.

91 MR. SCHECK:

All right. On--and in terms of the yield gels, is it a fair statement that 47, 48, 49, 50 and 52 were samples that were severely degraded in terms of bacterial DNA.

92 MR. CLARKE:

Objection, vague.

93 THE COURT:

Sustained.

94 MR. SCHECK:

What was the status of those samples in terms of bacterial degradation?

95 DR. GERDES:

They were all extremely degraded.

96 MR. SCHECK:

Now, with respect to 52, is this the RFLP result that you are concerned about?

97 DR. GERDES:

Yes.

98 MR. SCHECK:

How many nanograms of human DNA did Robin Cotton testify went into that particular result?

99 DR. GERDES:

She testified there was 25 nanograms.

100 MR. SCHECK:

Is that different than all of the other RFLP results?

101 DR. GERDES:

All the other RFLP results have more DNA, adequate DNA.

102 MR. SCHECK:

At least four times more?

103 DR. GERDES:

That's correct, at least four times more DNA.

104 MR. SCHECK:

Were any other of the samples from which RFLP results obtained, were those handled in the presence of the reference sample and in the period where the reference sample was handled?

105 MR. CLARKE:

Objection, no foundation.

106 THE COURT:

Sustained.

107 MR. SCHECK:

Is it your testimony, sir, that there were unacceptable risks of cross-contamination that are associated with the results on 47, 48, 49, 50 and 52?

108 DR. GERDES:

Yes.

109 MR. CLARKE:

Excuse me. Objection, leading.

110 THE COURT:

I will let it stand, but it was.

111 MR. SCHECK:

Now, there are frequency estimates on the right side of this chart for all those items?

112 DR. GERDES:

Yes, there are.

113 MR. SCHECK:

Could you distinguish for us between frequencies and error rates?

114 DR. GERDES:

Yes. I mean--these are an estimate of at what percentage of the population or what incidents in the population you might find all of these genetic markers. Error rate has to do with an evaluation of the laboratory itself and the question of how good are they in terms of how often they might make a mistake. And so on the one hand you are talking about how many--if you do a hundred samples, how often would you make an error?

115 MR. SCHECK:

In terms of--I'm sorry.

116 DR. GERDES:

On the other hand, you are talking about assuming there were no errors, how often would you find this in the population?

117 MR. SCHECK:

Do you agree with the recommendation of the national research council that laboratory error rate ought to be measured by the use of external blind proficiency tests on samples that replicate case work?

118 DR. GERDES:

I do.

119 MR. CLARKE:

Objection, hearsay, no foundation.

120 THE COURT:

Overruled.

121 DR. GERDES:

I do.

122 MR. SCHECK:

Does the LAPD have such a program?

123 DR. GERDES:

No, they don't.

124 MR. SCHECK:

In terms of their open proficiency tests, in your judgment do those proficiency tests replicate case work?

125 DR. GERDES:

No, they don't include mixtures or degraded DNA samples, DNA's of low concentrations.

126 MR. SCHECK:

In terms of the study that you performed looking at all the strips and runs at the LAPD laboratory, do you have a judgment as to how that--how personnel at that laboratory handle samples?

127 MR. CLARKE:

Objection, no foundation.

128 THE COURT:

Sustained.

129 MR. SCHECK:

From your study, is there an objective basis for making an assessment as to the risk of error until handling samples at the LAPD?

130 MR. CLARKE:

Same objection.

131 THE COURT:

Sustained. It is vague and overbroad. You need to pare it down a little.

132 MR. SCHECK:

In your study of contamination at the Los Angeles Police Department, in terms of their runs and strips, did you make an assessment of extraction controls versus amplification controls?

133 DR. GERDES:

I did.

134 MR. SCHECK:

And what was the significance of that?

135 DR. GERDES:

The--

136 MR. CLARKE:

Objection, vague.

137 THE COURT:

Overruled.

138 DR. GERDES:

The significance is that the contamination was found predominantly in the reagent extraction controls.

139 MR. SCHECK:

And what does that indicate about this phase of the DNA process where errors were correct?

140 DR. GERDES:

It indicates that in handling samples in the early stages, the extraction stages in both of those areas, that is where the contamination is being introduced in terms of what we can objectively look at, which is their record on doing known samples over the course of that time period.

141 MR. SCHECK:

And does that include the evidence processing room as one of those stages that the extraction control would cover?

142 DR. GERDES:

I believe it would.

143 MR. SCHECK:

Now, turning to the results from 117, the rear gate, are you aware, from your review of the testimony, as to the amount of DNA on that sample?

144 DR. GERDES:

Yes. There is 150 nanograms.

145 MR. SCHECK:

In your judgment is that significantly different than the amount of DNA on the other Bundy blood drops?

146 DR. GERDES:

Yes, it is.

147 MR. SCHECK:

Do you know when that sample was collected?

148 DR. GERDES:

Yes.

149 MR. SCHECK:

When?

150 DR. GERDES:

I don't know the exact date, but I believe it was collected in August.

151 MR. SCHECK:

July 3rd?

152 DR. GERDES:

July--July. Later after--a month or so after the samples.

153 MR. SCHECK:

The Bundy blood--and in terms of bacterial degradation, do you agree with the assessment of Gary Sims that 117 did not show evidence on yield gels of bacterial degradation?

154 MR. CLARKE:

Objection, no foundation.

155 THE COURT:

Sustained.

156 MR. SCHECK:

Are you aware of Mr. Sims testimony and assessment as to the level of bacterial degradation on item 117?

157 DR. GERDES:

Yes.

158 MR. SCHECK:

Do you agree with that?

159 DR. GERDES:

Yes.

160 MR. SCHECK:

Were those samples degraded?

161 DR. GERDES:

No.

162 MR. SCHECK:

Dr. Gerdes, does it make any sense to you, based on your knowledge of DNA quantitation, that samples collected on June 13th from the same area, that is 47, 48, 49, 50 and 52, would be so degraded in terms of bacterial contamination--bacteria, 117 would show no evidence of that?

163 MR. CLARKE:

Objection, no foundation, calls for speculation.

164 THE COURT:

Sustained.

165 MR. SCHECK:

All right. Does this data, in terms of the dates of collection and the conditions where those samples were collected, make sense to you scientifically?

166 MR. CLARKE:

Same objection.

167 THE COURT:

Sustained.

168 MR. SCHECK:

What is your assessment of the--can you explain the difference in DNA amounts and degradation on 117 versus 47 through 52?

169 MR. CLARKE:

Same objection.

170 THE COURT:

Sustained.

171 MR. SCHECK:

Are you aware of the testimony that the same methods of collection were employed by Dennis Fung in terms of putting the swatches from 117 into a plastic bag, taking them to the laboratory and drying them in test tubes and sampling the next day as was followed with 47?

172 DR. GERDES:

48, 49, 50 and 52.

173 MR. CLARKE:

Objection, misstates the evidence.

174 THE COURT:

Overruled.

175 DR. GERDES:

Yes, I am aware of that.

176 MR. SCHECK:

All right. Given that the same procedures were followed and given that all these items were in the locations where they were recovered, does it make any sense to you scientifically that there should be no evidence of degradation in 117 and so much evidence of degradation in 47 through 52?

177 MR. CLARKE:

Objection, no foundation, calls for speculation.

178 THE COURT:

Sustained.

179 (Discussion held off the record between Defense counsel.)
180 MR. SCHECK:

Have you looked at photographs of the scene where these different items were collected?

181 DR. GERDES:

Yes, I have seen photographs.

182 MR. SCHECK:

All right. So you are familiar with where they are collected?

183 DR. GERDES:

Yes.

184 MR. SCHECK:

In terms of their locations, in terms of the methods of--same methods of collection and in terms of the results with respect to bacterial degradation and yield of human DNA, did these results--what is your assessment of these results?

185 MR. CLARKE:

Same objection, same grounds.

186 THE COURT:

Sustained.

187 MR. SCHECK:

These are foundation?

188 THE COURT:

Foundation, counsel. It is a forensic setting.

189 (Discussion held off the record between Defense counsel.)
190 MR. SCHECK:

Well--

191 (Discussion held off the record between Defense counsel.)
192 MR. SCHECK:

All right. Dr. Gerdes--Dr. Gerdes, do you have a background in microbiology?

193 DR. GERDES:

Yes, I do.

194 MR. SCHECK:

Does microbiology involve an assessment of the effects of bacteria on DNA?

195 DR. GERDES:

Yes, it could.

196 MR. SCHECK:

Is that what you got your Ph.D. in?

197 DR. GERDES:

Yes.

198 MR. SCHECK:

Is that--have you relied on your microbiology background in terms of your postdoctorate work and your work as a DNA lab director?

199 DR. GERDES:

Yes.

200 MR. SCHECK:

Do those principles, basic scientific principles of microbiology and molecular genetics that you have been trained in, do those have application to an assessment of bloodstains, bacteria and substrates?

201 DR. GERDES:

Yes.

202 MR. SCHECK:

Have you read the literature from forensic laboratories that you've called demonstration papers that deal with degradation of samples taken from crime scenes?

203 DR. GERDES:

Yes.

204 MR. SCHECK:

Based on all of that, what is your assessment in terms of the data that the Bundy blood drops were severely degraded with bacteria and the rear gate sample 117 was not and the rear gate sample had 150 nanograms of DNA which was five times higher than any Bundy blood drop sample?

205 MR. CLARKE:

Same objection, same grounds.

206 THE COURT:

Overruled.

207 DR. GERDES:

It doesn't seem to make sense to me that you should see about the same level of degradation and in fact on 117, which is an older sample, should have more degradation.

KEY QUOTE
208 MR. SCHECK:

Thank you.

209 (Brief pause.)
210 MR. SCHECK:

Dr. Gerdes, I show you what's been marked as Prosecution's 260 entitled "Results of DNA analysis on the Bronco automobile." Were the results of the steering wheel, no. 29, from the laboratories, a 1.2, 1.1, 4?

211 DR. GERDES:

Yes, they were.

212 MR. SCHECK:

And taken at face value would that indicate a mixture of some--could indicate a mixture of somebody with a 1.1, 1.2 and somebody that is a 4?

213 DR. GERDES:

Yes.

214 MR. SCHECK:

A 4, 4, I should say?

215 DR. GERDES:

Yes.

216 MR. SCHECK:

And somebody that is a 1.2, 4?

217 DR. GERDES:

Yes.

218 MR. SCHECK:

And somebody that is a 1.1, 4?

219 DR. GERDES:

Yes.

220 MR. SCHECK:

And that result does not match, on the face of it, Mr. Goldman, correct?

221 DR. GERDES:

That's correct.

222 MR. SCHECK:

He would be excluded from the steering wheel?

223 DR. GERDES:

He would.

224 MR. SCHECK:

Now, with respect to item no. 31 and item no. 30, were those the only results from the Bronco console that were removed on June 14th?

225 MR. CLARKE:

Objection, no foundation.

226 THE COURT:

Sustained.

227 MR. SCHECK:

In terms of the sample removed from the Bronco on June 14th, I believe on direct examination you indicated what about those?

228 DR. GERDES:

Those are the samples that were removed on that date.

229 MR. SCHECK:

All right. And that--

230 DR. GERDES:

The low numbers indicate samples that are--that were collected on that early date. The high numbers, the hundreds, those are the later samples.

231 THE COURT:

So 303, 304, 305 were removed on August 26th?

232 DR. GERDES:

Correct.

233 MR. SCHECK:

All right. Now, in terms of 30 and 31, Mr. Clarke on his cross-examination of you, do you recall just pulled out this board and asked you to read the results, correct?

234 DR. GERDES:

That's correct.

235 MR. SCHECK:

He didn't ask you whether you believed that the result on 31 was scientifically acceptable?

236 MR. CLARKE:

Objection, irrelevant.

237 THE COURT:

Overruled.

238 DR. GERDES:

No, he didn't ask me.

239 MR. SCHECK:

All right. Your Honor, I would like to show another board over this for a second.

240 (Brief pause.)
241 THE COURT:

All right. Mr. Scheck, this is Defense exhibit--

242 MR. SCHECK:

1309.

243 THE COURT:

Thank you.

244 MR. SCHECK:

Entitled "Bronco console stains collected June 14th, 1994."

245 MR. SCHECK:

Dr. Gerdes, in light of the 1.3 appearing on the quality assurance sample 8--quality control sample 816 and the positive control, the intensities of those dots, the call that was made by DOJ, do you believe that it is scientifically acceptable, and I ask you this question to a reasonable degree of scientific certainty that makes a call that there is a contributor with a 1.3, 4 in this sample?

246 DR. GERDES:

Absolutely not. You can't tell if that is real or not because it is on the control. These stain signals--you can't arbitrarily say it is real here and it is not real down there, (Indicating), so you can't make that call.

KEY QUOTE
247 MR. SCHECK:

I would like to show 1310.

248 (Brief pause.)
249 MR. SCHECK:

1310 is entitled "Bundy blood drops LAPD item no. 13"?

250 DR. GERDES:

Yes.

251 MR. SCHECK:

"DOJ typing"?

252 DR. GERDES:

Yes.

253 MR. SCHECK:

Do you see an inconsistency in the call with respect to the 1.3 on LAPD item 52 and the call on the 1.3 on sample 31?

254 MR. CLARKE:

Objection, leading, also argumentative.

255 THE COURT:

Sustained. Rephrase the question.

256 MR. SCHECK:

What is your view of the call that was made on item 52 with respect to the 1.3 allele and the call that was made to item 31?

257 MR. CLARKE:

Objection, no foundation.

258 THE COURT:

Overruled.

259 DR. GERDES:

This just shows the subjectivity of this. In this case the 1.3 is not--is ignored in this particular time. On the other time it is counted and on the controls it is counted, so there is no scientific basis as to how you would determine one of these as real and one as not real, other than--I don't know how you would decide.

KEY QUOTE
260 MR. SCHECK:

Dr. Gerdes, if we were to assume that the 1.3 is real on item no. 52, ask you to keep that assumption in mind, first question is out of all the different systems used, is the DQ-Alpha system the most sensitive?

261 DR. GERDES:

Yes, it is.

262 MR. SCHECK:

So if--I ask you to assume that DNA on the Bundy blood drops 47, 48, 49, 50 and 52 is degrading because of bacteria.

263 DR. GERDES:

Yes.

264 MR. SCHECK:

And that 52--on sample 52, consistent with that 1.3 because the DQ-Alpha is the most sensitive system. If you assume that to be real--

265 DR. GERDES:

Yes.

266 MR. SCHECK:

--DNA from another contributor--

267 MR. CLARKE:

Objection, calls for speculation.

268 THE COURT:

Sustained.

269 MR. SCHECK:

Well, let us assume that DNA on item no. 53 underwent--52--underwent a process of bacterial degradation. Do you have that in mind?

270 DR. GERDES:

I have it.

271 MR. SCHECK:

Let us further assume that there was contamination with Mr. Simpson's reference sample on June 14th at the LAPD laboratory. Do you have that in mind?

272 DR. GERDES:

Yes.

273 MR. SCHECK:

All right. In theory, if that 1.3 is real, could that represent the contribution of the original source on sample 152 which had degraded?

274 MR. CLARKE:

Same objection.

275 THE COURT:

Overruled.

276 DR. GERDES:

Yes, it definitely could.

277 MR. SCHECK:

If it were real?

278 DR. GERDES:

Yes, if it were real.

279 (Brief pause.)
280 MR. SCHECK:

Your Honor, I think that--I don't have another minute and 30 seconds.

281 THE COURT:

You are done?

282 MR. SCHECK:

No. I don't have much more, but I don't have another minute and 30 seconds--

283 THE COURT:

All right.

284 MR. SCHECK:

--on this line.

285 THE COURT:

All right. Why don't you take that down for me, please.

Temperature

tense

Key Quotes (4)

Dr. John Gerdes
Once you've accidentally or some other way transferred that DNA from one sample to another, it doesn't matter how many gene systems, how many different labs, it is always going to transfer, it is always going to type as the DNA that was transferred.
Core rebuttal to Clarke's cross-examination point that multiple independent labs confirmed results — Gerdes argues downstream replication is irrelevant if contamination occurred upstream at LAPD.
Dr. John Gerdes
It doesn't seem to make sense to me that you should see about the same level of degradation and in fact on 117, which is an older sample, should have more degradation.
Gerdes directly questions the authenticity of item 117 (rear gate blood), suggesting its pristine condition versus the degraded Bundy drops is scientifically inconsistent — implying it may have been planted.
Dr. John Gerdes
Absolutely not. You can't tell if that is real or not because it is on the control. These stain signals--you can't arbitrarily say it is real here and it is not real down there, so you can't make that call.
Gerdes attacks DOJ's subjective interpretation of the 1.3 allele call on Bronco console item 31, arguing the result is scientifically unacceptable given the positive control showed the same signal.
Dr. John Gerdes
This just shows the subjectivity of this. In this case the 1.3 is not--is ignored in this particular time. On the other time it is counted and on the controls it is counted, so there is no scientific basis as to how you would determine one of these as real and one as not real.
Exposes inconsistent allele calling between item 52 and item 31, undermining the objectivity of the prosecution's DNA analysts.

Evidence (10)

People's 564-F
Slides showing DQ-Alpha typing results at LAPD laboratory for Bundy blood drop items 48, 50, and 52
discussed, used to establish which samples Yamauchi handled alongside Simpson reference sample
Defense 1311
Printed photograph/screenshot of the flow chart with evidence processing room circled, showing June 13-14 handling procedures
introduced
Defense 259
Bundy results board showing DNA typing results and population frequency estimates for items 47-52
discussed
Defense 1165
Charts showing nanogram quantities of DNA in Bundy blood drop items
discussed alongside 259
People's 260
Results of DNA analysis on the Bronco automobile, including steering wheel and console samples
discussed — Gerdes confirms Goldman excluded from steering wheel result
Defense 1309
Chart titled 'Bronco console stains collected June 14, 1994' showing DOJ typing results for item 31
introduced, used to challenge scientific acceptability of 1.3 allele call
+ 4 more

Notable Exchanges (4)

Barry ScheckDr. John Gerdes
Scheck walked Gerdes through the June 13-14 handling sequence item by item (47, 48, 49, 50, 52), getting Gerdes to confirm each was handled by both Fung/Mazzola and Yamauchi in proximity to Simpson's reference sample — building a cumulative contamination narrative.
methodical, strategic
Barry ScheckDr. John GerdesGeorge ClarkeJudge Ito
Scheck made repeated attempts to get Gerdes to opine that item 117's lack of degradation compared to the Bundy drops was scientifically inexplicable — Clarke objected on foundation/speculation grounds each time and Ito sustained, forcing Scheck to repeatedly lay additional foundation before Ito finally overruled.
frustrated, persistent
Barry ScheckDr. John Gerdes
Scheck used a hypothetical assumption chain to get Gerdes to acknowledge that the 1.3 allele on item 52 could represent the original contributor's DNA that had degraded — threading the needle between Ito's speculation objections by framing it conditionally.
careful, strategic
Barry ScheckJudge Ito
Scheck complained he didn't have 'another minute and 30 seconds' on his current line of questioning, suggesting a time constraint was in play as he approached what appeared to be a logical break point in the examination.
procedural

Credibility Attacks (5)

⚔ LAPD crime lab / Collin Yamauchi
evidence of systemic contamination, failure to follow protocol
Gerdes testified that Yamauchi's handling of Simpson's reference sample simultaneously with Bundy blood drops — including the incident where blood went through a chem wipe onto his glove — created unacceptable cross-contamination risk, and that LAPD's extraction controls showed contamination was introduced in early-stage handling.
⚔ Dennis Fung / Andrea Mazzola
failure to follow protocol
Gerdes confirmed they removed wet swatches from plastic bags, placed them in test tubes, and scraped them out the next day without changing gloves or paper — handling Bundy drops, Rockingham items, and item 12 together, creating aerosol risks.
⚔ DOJ / Gary Sims (implied)
inconsistent and subjective allele calling
Gerdes testified that the 1.3 allele was ignored on item 52 but counted on item 31's Bronco console sample, and that when the same signal appeared on positive controls it was attributed to artifact — demonstrating no objective scientific standard governed the calls.
⚔ LAPD crime lab
inadequate proficiency testing
Gerdes testified LAPD had no blind external proficiency testing program as recommended by the NRC, and that their open proficiency tests did not replicate casework conditions (no mixtures, degraded DNA, or low-concentration samples).
⚔ Item 117 (rear gate sample)
scientific implausibility of results
Gerdes testified that 117 containing 150 nanograms with no bacterial degradation — while Bundy drops from the same scene collected weeks earlier were severely degraded — 'doesn't seem to make sense,' implicitly supporting the defense theory that the sample was planted.

Objections

24 objections (13 sustained, 7 overruled)
Proceeding 7212 • 285 utterances • Defense witness
Criminal Trial
Department 103
⚖️ Start
📂 AUG 7, 1995 📄 Redirect examination of Dr. Jo
AUG 7, 1995 KRT DvH TD